Company intelligence / Profile preview

Sorin New Ventures

Milan, Italy

Ownership: Private
Development stage: Other

Overview

Sorin New Ventures was the strategic venture capital and corporate development arm of Sorin Group (now part of LivaNova), a global leader in the treatment of cardiovascular diseases. The unit focused on investing in and incubating early-stage medical technology companies with high-growth potential in the cardiovascular and rhythm management spaces. Its portfolio included innovative startups working on neuromodulation for heart failure, percutaneous mitral valve repair, and advanced cardiac monitoring systems. Following the 2015 merger between Sorin Group and Cyberonics to form LivaNova, these venture activities were integrated into the parent company's broader corporate strategy.

Therapeutic areas: CardiovascularPulmonology
Modalities: Device
Industry: Investors

Beyond the preview

Go deeper on Sorin New Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorin New Ventures.

Explore the full profile